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INTRODUCTION
Amyloid fibril formation is associated with over 40 diseases 1 including Alzheimer's disease,
2
Parkinson's disease, [3] [4] [5] [6] type II diabetes 7, 8 , and dialysis-related amyloidosis. 9, 10 Of these, Alzheimer's disease (AD) is the most prevalent, currently affecting an estimated 5.5 million Americans according to the Alzheimer's Association. By 2050 the patient population is expected to grow to 16 million people,
providing an imperative to develop diagnostic and therapeutic protocols to address AD. Multiple lines of evidence indicate that the aggregation of β-amyloid (Aβ) peptide is integral to the disease pathogenicity.
Aβ peptides are generated by the cleavage of the amyloid precursor protein (APP) by the membrane associated β-and γ-secretases, 11, 12 yielding a variety of Aβ with different lengths, the two most common being Aβ1-40 (APP 672-711) and Aβ1-42 (APP 672-713). The former is more abundant and the latter is significantly more amyloidogenic and neurotoxic. 13, 14 The difference between the two isoforms is the addition of I41 and A42 (APP 712-713), which dramatically alters the aggregation kinetics, 15 neurotoxicity, 16 and structure. [17] [18] [19] Furthermore, it has recently been demonstrated that AβM01-40 and AβM01-42 do not cross seed one another, while each one is highly efficient in self-seeding, suggesting as well that fibrils of Aβ40 and Aβ42 possess different structures.
17, 20
A more detailed understanding of Aβ in its various aggregated forms is vital to determining its pathogenicity and structure, both of which are necessary for rational design and development of diagnostic and therapeutic tools. To that end, substantial efforts have been devoted to understanding the details associated with the mechanism of aggregation as well as aggregate structure and how these features relate to toxicity 1, [21] [22] [23] . Aβ fibrils are sparingly soluble and do not diffract to high resolution, rendering conventional tools for biological structure determination such as solution NMR spectroscopy and X-ray diffraction of limited utility in characterizing fibril samples. Fortunately, magic angle spinning (MAS) nuclear magnetic resonance (NMR) spectroscopy has proven to be a powerful technique to elucidate the structural details of amyloid fibrils on an atomic level, including backbone conformations, supramolecular organization, and registry of inter-strand arrangements of amyloid fibrils.
24-26
Because of their relatively short length, A1-40 and A1-42 peptides used in MAS NMR spectroscopy and in many other biophysical studies have historically been prepared via peptide synthesis. In the case of NMR experiments, this permits specific labeling of individual residues that was necessary because of the broad linewidths (2-4 ppm) observed in early spectra. [27] [28] [29] However, the recent report that recombinant A1-42 aggregates significantly faster and is more neurotoxic when compared with synthetic A1-42 16 has stimulated significant interest in developing recombinant methods for preparation. In particular, recombinant A is more neurotoxic in cultured rat primary cortical neurons, and more toxic in vivo, as demonstrated by enhanced induction of abnormal phosphorylation of tau leading to tau aggregation into neurofibrillary tangles in brains of transgenic mice. 16 Recombinant A1-42 is therefore likely more relevant to the pathogenicity of AD than is synthetic protein. 16 The origin of the differences between synthetic and recombinant A are not completely understood, but could be due to racemization and/or coupling errors that occur during synthesis leading to a large number of similar sequences. Such impurities are very difficult to separate. In contrast, recombinant expression in for example E. coli provides excellent fidelity with respect to both sequence homogeneity and chirality. Finally, for NMR structure experiments it is desirable to prepare uniformly 13 Currently several methods exist to produce recombinant Aβ containing an N-terminal methionine. Its small size and its propensity to aggregate permit direct expression resulting in the formation of inclusion bodies. This approach has been widely used to prepare A due to the ease of production and purification. 54 Although this method is effective, it leaves an N-terminal methionine (M0) residue whose impact on the aggregation of Aβ and the fibril structure is as yet unknown. Peptides cleaved just before M671 have to our knowledge not been observed in human samples, even though in APP, M671 precedes D672, numbered D1 in the released Aβ peptides, many variants with extended N-termini are found in blood and CSF 55, 56 Furthermore, while N-terminal extension of A with 5-40 residues from APP has been found to retard aggregation in a manner proportional to the length of the extension 57 the effect of the N-terminal methionine in AβM01-42 on the aggregation mechanism and rate remains to be found.
AβM01-40, AβM01-42, as well as the N-terminally extended variants all aggregate by the same general mechanism, which relies on at least three microscopic steps: primary nucleation of monomers in solution, elongation by monomer addition at fibril ends and secondary nucleation of monomers on fibril surfaces. 15, 57, 58 The difference between the Aβ length variants lies in the rate constants of these three processes and one could imagine that the N-terminal methionine may have an impact on some rate constants or produce structurally different Aβ fibrils from those produced sans the N-terminal 64 Although these preparations were used previously, they were typically for Aβ1-40 and the yields reported make it challenging to generate sufficient material to fill an MAS NMR rotor (~30 mgs). Recently a preparation using SUMO (small ubiquitin-like modifier) as an N-terminal fusion protein was reported, which possessed excellent protein overexpression yields in rich media.
65, 66
Here, we chose to utilize this construct to overexpress the SUMO-Aβ1-42 fusion protein in isotopically enriched minimal media and have modified the purification to produce sufficient quantities of Aβ monomers for kinetic experiments and subsequently for fibrils for MAS NMR spectra.
Measurements of the aggregation kinetics revealed only very small differences between AβM01-42 and Aβ1-42, all rate constants are within a factor of 2.5, and this along with the ability of AβM01-42 and Aβ1-42 to cross seed each other, suggest that both the mechanism of aggregation and fibril structure are highly similar. For more detailed structural comparison, we compared the MAS NMR spectra of AβM01-42 with Aβ1-42 and found few chemical shift differences among residues in the fibril core. Thus, the presence of an additional methionine on the N-terminus has little impact on the aggregation rate, or fibril core structure as ascertained by MAS NMR. More explicitly, these findings indicate that the mechanism of aggregation is likely similar, and that the microscopic structure of the amyloid core is identical.
EXPERIMENTAL
Preparation of SUMO-Hydroxlyase. The expression and purification of His6-tagged SUMO-1 protease (ULP-1-His6) has been described in detail previously, 67 and is summarized below. The plasmid coding for ULP-1-His6 was kindly provided by Dr. Jens Tyedmers (University Heidelberg, Germany). ULP-1-His6 was overexpressed in E. coli BL21 (DE3) by inoculating 100 mL of LB medium by a single colony and was grown overnight at 30°C. 5 mL of the overnight culture was added to 1 L of LB broth and grown at 30°C until an OD600=1.0 was reached. Subsequently the temperature was lowered to 20°C
followed by addition of 0.5 mM isopropyl -D-1-thiogalactopyranoside (IPTG) one hour after temperature change. Expression were conducted over night and cells were subsequently harvested and stored at -80°C. The pellet was subjected to two freeze-thaw cycles (frozen in liquid N2 and thawed in a Following dialysis, the sample was concentrated using a 10 kDa centrifugal concentrator to a final volume of 2 mL with an equal volume of glycerol added, and 100 μL aliquots were stored at -80°C until used.
Preparation of Aβ1-42. DNA coding for SUMO and Aβ was extracted from commercial vectors and prepared by de novo gene synthesis, respectively, and overlapped via PCR to generate a chimeric construct of SUMO fused with Aβ1-42 containing the gateway handles (e.g. attR1 and attR2). The DNA coding for SUMO-Aβ1-42 was inserted into a pDEST17 vector containing an N-terminal His6 tag via gateway cloning and transformed into BL21 Star (DE3) pLysS cells (Invitrogen), individual colonies were sent for DNA sequencing, and appropriate colonies were cultured overnight in 5 mL of LB broth (100 μg/mL ampicillin and 38 μg/mL of chloramphenicol), with glycerol stocks prepared the following morning. 200 μL of the glycerol stock was plated onto LB agar containing 100 μg/mL ampicillin and 38 μg/mL of chloramphenicol and grown overnight at 37°C. Several single colonies were used to inoculate 50 mL LB medium containing 100 μg/mL ampicillin and 38 μg/mL of chloramphenicol and cultured over night at 37°C. Subsequently, 1 ml of each over-night culture was used to inoculate 500 mL of M9 medium consisting of 2 g/L glucose, 1 g/L NH4Cl, 2 mM MgSO4, 100 μM CaCl2, 10 mg/L thiamine, 10 mg/L of FeSO4, 100 μg/mL ampicillin, and 38 μg/mL of chloramphenicol. Cells were grown at 37°C
until an OD600 of 0.8 was reached, at which time overexpression was induced with IPTG. Cells were allowed to express at 37°C for four hours, and were subsequently harvested by centrifugation and stored at -80°C. Typically, a final OD600 of 1.8-2.0 was reached prior to pelleting.
Cell pellets were thawed and resuspended in 10 mM Tris pH 8.0, 1 mM EDTA (buffer C) and sonicated (Branson Sonifier 450) on ice for 2 minutes and pelleted for 10 minutes at 15,000g. The supernatant was removed, the pellet was resuspended in buffer C and sonicated three additional times, for times of 30 seconds, 20 seconds and 15 seconds, respectively, each sonication was followed by centrifugation for five minutes. Subsequently the remaining pellet was dissolved in lysis buffer (buffer C + 8 M urea) and sonicated for 2 minutes followed by 2 minutes rest (3x), followed by centrifugation at 15,000g for 15 minutes. The supernatant was decanted and subsequently diluted with buffer C by a factor of 4 to yield 2 M urea and added to 30 mL of DEAE cellulose. The protein was allowed to bind for 30-60 min, and the resin was subsequently loaded into a column. The column was then washed with 50 mL of buffer C + 2 M urea with increasing amounts of NaCl: 10 mM (2x), 25 mM (2x), 75 mM (1x), 200 mM (4x), and 500 mM (1x). We found that SUMO-Aβ1-42 elutes at 200 mM NaCl. The eluate was concentrated by a factor of four in a centrifugal concentrator (3.5 kDa cutoff), followed by dilution by a factor of four with buffer C, to yield 0.5 M urea in buffer C. A representative yield of the SUMO-Aβ fusion protein is ~100 mg/L M9 minimal medium. ULP-1 was added immediately after dilution and the fusion protein allowed to cleave for at least two hours at room temperature, followed by lyophylization.
The lyophilized material was dissolved in 6 M GuHCl and subjected to size exclusion chormatography and emission filter 480 nm). The data were analyzed globally using the AmyloFit interface. 68 with the equations described in references 58 and 68
MAS NMR spectroscopy.
Fully formed (mature) fibrils were packed into a 3.2 mm Bruker rotor using a home-built centrifugal packing tool. Spectra were recorded on a Bruker 800 MHz AVANCE III spectrometer equipped with a 3.2 mm triple channel HCN Bruker probe (Bruker Biospin, Billerica, MA). Spectra were recorded at ωr/2π = 20 kHz and regulated to ±10 Hz using a Bruker spinning frequency controller. All experiments were conducted at 277 K. Spectra were processed using TopSpin 3.1, and analyzed in Sparky.
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RESULTS AND DISCUSSION
Preparation of Aβ1-42. The SUMO fusion protein was placed N-terminally of Aβ1-42 to eliminate the M0 residue present when directly expressed in E. coli. Most of the SUMO-Aβ fusion protein is in the supernatant following lysis, and that it can be effectively separated using DEAE cellulose resin (data not shown). The SUMO fusion protein is cleaved by SUMO-1 protease (ULP-1-His6, Figure 1 ) which recognizes and cleaves SUMO based on SUMO's tertiary structure, 67 necessitating that SUMO be refolded following lysis. We found that SUMO-Aβ has a propensity to aggregate in the absence of a denaturant and therefore the SUMO-Aβ fusion protein was cleaved with 0.5 M urea present, the highest concentration of urea that would permit reasonable cleavage yields (data not shown).
Following cleavage, Aβ1-42 was separated from SUMO using size exclusion chromatography in an identical manner to the purification employed before preparing AβM01-42 fibrils. fluorescence data for fibril formation versus time for all peptide concentrations globally. While models including only primary nucleation and elongation, or primary nucleation, elongation and fragmentation failed to fit the data, as previously found for AβM01-42, 58 a model including primary nucleation, elongation and secondary nucleation produced acceptable global fits to the data as shown in Figure 2A .
This analysis further revealed that all rate constants are within a factor of 2.5 when the two peptides are compared, and there is a slightly higher dominance of the secondary pathway in the shorter peptide. Still the difference between the two peptides is so small that the main finding is that there is no major change in mechanism or rate constants. For the product rate constant k+k2, we obtain a value of 1 x 10 11 M -3 s -2
for Aβ1-42 (vs. 4 x 10 10 M -3 s -2 for AβM01-42) 58 while we obtain similar values for the combined rate constant k+kn for both peptides (900 M -2 s -2 ). As a comparison, removing two residues at the C-terminus leads to a 1800-fold reduction in k+kn and a 44-fold reduction in k+k2. 15 However, the minor difference in aggregation kinetics between Aβ1-42 and AβM01-42 does not provide information about the atomic level structure of the two fibrils.
Fibrils of A1-42 and AM01-42 have rigid and dynamic regions. To compare the structures of AM01-42
and A1-42, we therefore recorded MAS NMR spectra to determine what impact, if any, the N-terminal methionine has on the microscopic structure of A42 fibrils. Amyloid fibrils of AM01-42 have a rigid amyloid core that sequesters residues Q15-A42 into parallel in register beta sheets while residues M0-H14 are less ordered. 17 Overall, removal of the M0 did not result in striking change in the rigid regions of these fibrils.
We collected 1D 13 C and 15 N cross-polarization spectra that were recorded at 0H/2=800 MHz. We note that the 13 C cross polarized spectrum ( Figure 3A ) of Aβ1-42 is slightly more well resolved than AβM01-42, possibly due to a more compact core structure, but is otherwise comparable with respect to chemical shifts. Similarly, the amide region of the 15 N cross polarization spectrum of Aβ1-42 ( Figure 3C) is similar to that of AβM01-42. However, there are some differences in the side chains. The lysine signal for Aβ1-42 fibrils consists of two lines with one more intense than the other and the arginine resonances are more intense than they are in AM01-42 fibrils. In the case of the lysine signals we assigned the more intense component to K28 and the latter to K16 that is difficult to observe in AβM01-42 in 2D and 3D spectra. 17 Similar statements are applicable to the R5 resonances in AM01-42 where we observed that the (Figure 4) . We collected these spectra using short dipolar mixing times and these spectra report on one and two bond correlations. To probe for longer-range correlations we also collected a small number of additional peaks in the spectra of Aβ1-42 fibrils. The resonance signals in Aβ1-42 that most prominently exhibited increased intensity were A21, E22 and D23 (Figure 4) . These peaks were considerably weaker in spectra of AβM01-42. Interestingly, these residues reside in the 'toxic corner' of the recently published structure of AβM01-42 that showed increased flexibility for these residues compared to the rest of the fibril core. However, it is not clear if these intensity variations are due to the presence or absence of the N-terminal methionine or if these occur for some other reason such as minor variations in pH or ionic strength during fibril growth. summarized pictorially in Figure 6 . The most prominent difference is at K16 and amounts to ~0.37 ppm and V36 and which is 0.23 ppm. K16 is the residue that is directly adjacent to the beginning of the disordered region in AM01-42 fibrils (Figure 6B, red) . Because the other differences were smaller than 0.15 ppm, which is less than the error in our experiments, we conclude that M0 does not have a significant effect on the structure of the A1-42 core.
Interestingly, there are several peaks present in the 13 spectrum. Leaving aside the obvious difference that results from the additional methionine in AM01-42, the most apparent differences were for the aromatic resonances of F4, which were more intense in spectra of A1-42 fibers than in AβM01-42 fibrils. (Figure 7 , see also Figure 3 ). As indicated in the INEPT spectra (Figure 3) , the INEPT-TOBSY spectra demonstrate that Aβ1-42 has several flexible residues, and that some, but not all of these residues are distinct from those in AβM01-42. Overall this suggests that M0 may change the mobility of the flexible N-terminus by predisposing this region to sample a variety of transient interactions with the amyloid core that are non-specifically driven by the hydrophobicity of the methionine side chain. When the methionine is removed, the energetically preferred interaction point between the flexible tail and the core uses F4 as a tether point, leading to a small number of additional peaks in the dipolar-selective spectra.
Conclusions
We report a new preparation method to produce and purify Aβ1-42 in sufficient yield to produce samples for MAS NMR spectroscopy. Monomers isolated by size exclusion chromatography can be incubated to yield fibrils of a monomorphic fibril core that exhibits excellent resolution and permitted us to determine a structure whose core is identical to that of AM01-42. In particular, by comparing the MAS NMR spectra of Aβ1-42 with and without an N-terminal methionine, we determined that this residue has little impact on the structure of the fibril's core, as the chemical shifts are nearly identical between the two different species. Yet, despite this striking structural conservation, we found that the deletion of the N-terminal methionine residue changes these fibers in subtle ways. Aβ1-42 fibers are more rigid than AM01-42 fibers, which is seen as a small increase in the number of interactions (a handful of new peaks become visible) and a change in the dynamics of some regions of the core (increased peak intensities, particularly in the "toxic corner" of the fibril). Because Aβ1-42 and AM01-42 follow the same aggregation mechanism with highly similar rate constants and because these dynamic differences are minor, structural studies that use an AM01-42 should be generalizable to Aβ1-42. However, investigations of the role of the disordered regions and their possible interactions should consider M0 as a variable.
